Pascale achieves unparalleled results by understanding the intricacies of a well-run healthcare PR campaign and implementing it seamlessly. In one case study, Pascale’s client, Imprimis Pharmaceuticals, introduced an alternative to the lifesaving medication Daraprim that cost a mere $0.99. (Turing Pharmaceuticals provoked outrage when it raised the price of Daraprim from $13.50 per pill to $750.) Imprimis had to do more than just announce its pill’s availability. Pascale seized the opportunity by sparking on-going conversations to the media, creating new angles to the story and generating exponentially more coverage for the organization.